Literature DB >> 19639275

[Imaging of nasopharyngeal diseases].

S Kösling1, S Knipping, T Hofmockel.   

Abstract

This article gives an overview about the main nasopharyngeal pathologies and incidental findings, which a radiologist could be confronted with in daily practice. These include nasopharyngeal cysts, lymphoid hyperplasia, juvenile angiofibroma, carcinomas and non-Hodgkin lymphoma. Typical radiological findings, possibilities for making a specific diagnosis, differential diagnosis and description of the spread of a neoplasm are the central points. Investigation techniques and clinical signs are briefly summarized.

Entities:  

Mesh:

Year:  2009        PMID: 19639275     DOI: 10.1007/s00106-009-1966-4

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  17 in total

1.  Extraorbital inflammatory pseudotumor of the head and neck: CT and MR findings in three patients.

Authors:  S De Vuysere; R Hermans; R Sciot; I Crevits; G Marchal
Journal:  AJNR Am J Neuroradiol       Date:  1999 Jun-Jul       Impact factor: 3.825

2.  Persistent hypophyseal (craniopharyngeal) canal.

Authors:  M L Hughes; A T Carty; F E White
Journal:  Br J Radiol       Date:  1999-02       Impact factor: 3.039

3.  A heterotopic cerebellum presenting as a suprasellar mass with associated nasopharyngeal teratoma.

Authors:  D Takhtani; E R Melhem; B S Carson
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

Review 4.  Posttreatment imaging of the nasopharynx.

Authors:  Shu Hang Ng; Hon Man Liu; Sheung Fat Ko; Sheng Po Hao; Vincent F H Chong
Journal:  Eur J Radiol       Date:  2002-11       Impact factor: 3.528

Review 5.  Radiological findings in angiofibroma.

Authors:  B Schick; G Kahle
Journal:  Acta Radiol       Date:  2000-11       Impact factor: 1.990

6.  Localized nasopharyngeal amyloidosis with remarkable early enhancement on dynamic contrast-enhanced MR imaging.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Tsutomu Araki; Syuuichiro Endo; Keisuke Masuyama; Tadao Nakazawa
Journal:  Eur Radiol       Date:  2006-05-19       Impact factor: 5.315

Review 7.  Nasopharyngeal liposarcoma MRI imaging features and a review of the literature.

Authors:  S Chakraborty; E E Kassel; E Yu
Journal:  Br J Radiol       Date:  2007-07       Impact factor: 3.039

8.  Imaging of nasopharyngeal atresia.

Authors:  J K Smith; M Castillo; S Mukherji; J Buenting; A Drake
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

9.  Juvenile angiofibroma: imaging by magnetic resonance, CT and conventional techniques.

Authors:  G A Lloyd; P D Phelps
Journal:  Clin Otolaryngol Allied Sci       Date:  1986-08

Review 10.  Neoplastic diseases affecting the central skull base: CT and MR imaging.

Authors:  L E Ginsberg
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

View more
  4 in total

1.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

2.  PET/MRI in head and neck cancer: initial experience.

Authors:  Ivan Platzek; Bettina Beuthien-Baumann; Matthias Schneider; Volker Gudziol; Jens Langner; Georg Schramm; Michael Laniado; Jörg Kotzerke; Jörg van den Hoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-28       Impact factor: 9.236

3.  Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR.

Authors:  Claes N Ladefoged; Adam E Hansen; Sune H Keller; Barbara M Fischer; Jacob H Rasmussen; Ian Law; Andreas Kjær; Liselotte Højgaard; Francois Lauze; Thomas Beyer; Flemming L Andersen
Journal:  EJNMMI Phys       Date:  2015-03-11

4.  Pathologic Evaluation of Routine Nasopharynx Punch Biopsy in the Adult Population: Is It Really Necessary?

Authors:  Sami Bercin; Gokhan Yalciner; Togay Muderris; Fatih Gul; H Mervan Deger; Muzaffer Kiris
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-27       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.